The Concise Manual of Apheresis Therapy [electronic resource] /edited by Eisei Noiri, Norio Hanafusa.
by Noiri, Eisei [editor.]; Hanafusa, Norio [editor.]; SpringerLink (Online service).
Material type:
BookPublisher: Tokyo : Springer Japan : 2014.Description: XXVII, 418 p. 46 illus., 39 illus. in color. online resource.ISBN: 9784431544128.Subject(s): Medicine | Internal medicine | Nephrology | Biomedical engineering | Medicine & Public Health | Nephrology | Internal Medicine | Biomedical EngineeringDDC classification: 616.61 Online resources: Click here to access online | Item type | Current location | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|
| MAIN LIBRARY | RC902-918 (Browse shelf) | Available |
Browsing MAIN LIBRARY Shelves Close shelf browser
| GE195-199 Sustainable Transport Studies in Asia | GE300-350 Approaches to Study Living Foraminifera | QA611-614.97 Geometric Aspects of General Topology | RC902-918 The Concise Manual of Apheresis Therapy | HT390-395 Basic and Clinical Environmental Approaches in Landscape Planning | GB450-460 Studies on the 2011 Off the Pacific Coast of Tohoku Earthquake | HB1-846.8 Symmetry and Economic Invariance |
Part 1. Principles and Technologies -- Chapter 1. Theoretical background of Apheresis Therapy - Norio Hanafusa -- Chapter 2. Methods to Remove Pathogens - Tamami Tanaka -- Chapter 3. Decision to Prescribe PE, DFPP, or PA- Rei Isshiki -- Chapter 4. Plasma Exchange - Daisuke Katagiri -- Chapter 5. Double Filtration Plasmapheresis - Daisuke Katagri -- Chapter 6. Plasma Adsorption- Yasuyuki Watanabe -- Chapter 7. Cryofiltration - Daisuke Katagiri -- Chapter 8. Double Filtration Plasmapheresis Thermo-mode (DF Thermo)- Mizuki Yamano -- Chapter 9. Plasma Diafiltration - Hajime Nakae -- Chapter 10. Direct Plasma Adsorption - Mayumi Miwa -- Chapter 11. Cytapheresis - Yuki Itoh -- Chapter 12. Cell-free and Concentrated Ascites Reinfusion Therapy - Norio Hanafusa -- Part 2. Therapeutic Details -- Chapter 13. Choice of Apheresis Therapy- Eisei Noiri -- Chapter 14. Determination of Dosage and Frequency of Therapy- Norio Hanafusa -- Chapter 15. Vascular Access- Koji Okamoto -- Chapter 16. Anticoagulants - Tetsushi Yamashita -- Part 3. Complications -- Chapter 17. Hypotension - Tsuyoshi Inoue -- Chapter 18. Bleeding Complications and Reduction of Coagulation Factors- Norio Hanafusa -- Chapter 19. Allergies - Motonobu Nakamura -- Chapter 20. Electrolytes Disorders - Motonobu Nakamura -- Chapter 21. Avoiding Complications during Apheresis - Tetsushi Yamashita -- Chapter 22. Infections - Osamu Yamazaki -- Part 4. Autoimmune Disorders -- Chapter 23. Neurological Diseases- Masao Iwagami -- Chapter 24. Dermatological Disorders- Masao Iwagami -- Chapter 25. Kidney Diseases- Masao Iwagami -- Chapter 26. Rheumatoid Arthritis and Collagen Diseases - Hiroko Kanda -- Chapter 27. Blood type incompatible pregnancies - Norio Hanafusa -- Chapter 28. Multiple Myeloma - Tsuyoshi Inoue -- Chapter 29. Dilated Cardiomyopathy - Yoshifumi Hamasaki -- Part 5. Pathogens with Large Molecular Weight.- Chapter 30. Low Density Lipoprotein Apheresis - Kenjiro Honda -- Chapter 31. Endotoxin Adsorption Therapy - Kent Doi -- Part 6. Diseases Necessary to Supply Coagulation Factors -- Chapter 32. Liver Diseases - Kent Doi.- Chapter 33. Thrombotic Thrombocytopenic Purpura and Thrombotic Microangiopathy - Kenjiro Honda.- Chapter 34. Inflammatory Bowel Diseases - Tsuyoshi Inoue.- Chapter 35. Hepatitis C Virus Infection - Shi Lu.- Chapter 36. Drug Intoxications - Motonobu Nakamura -- Chapter 37. Living Related Kidney Transplantation - Hiroo Kawarazaki -- Chapter 38. Peripheral Blood Stem Cell Transplantation- Naoko Watanabe-Okochi -- Part 7. Pediatric Apheresis -- Chapter 39. Apheresis in Children - Motoshi Hattori.
This pocket-sized manual serves as a concise and ideal reference work for therapeutic approaches using apheresis. Covering both basic theory and clinical details to facilitate improved treatment and patient outcomes, the text considers a variety of diseases, including myasthenia gravis, multiple sclerosis, Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, nephrotic syndrome, TTP/TMA, dilated cardiomyopathy, and many other conditions. The book also reviews the growing trend toward adopting this unique therapy for a wide range of health management issues such as morbid obesity and/or type 2 diabetes, and for lowering LDL-cholesterol (cholesterol apheresis) in patients unresponsive to medication or lifestyle modification.
There are no comments for this item.